Will CROs Find Opportunity in a Reinvigorated European R&D Sector? Outsourcing Outlook

News
Article
Pharmaceutical TechnologyPharmaceutical Technology-10-02-2002
Volume 26
Issue 10

The European Union is attempting to reform its current business environment in hopes of restoring its role in the lobal R&D sector.

Recent Videos
Drug Digest: Strategic Partnerships
Henny Zijlstra from Adragos Pharma chats about the trends affecting the outsourcing market, various strategies being employed by service providers, and the value of end-to-end services.
Tore Bergsteiner from MAIN5 details his predictions for how the mega trends will shape the bio/pharma industry in 2025 and beyond.
Simon Wright from Almac Pharma Services chats about shifting demand for commercial manufacturing services and how service providers are adapting to meet demand.
Related Content